NEW YORK, Sept. 28, 2026 /PRNewswire/ — TO: ALL RECORD HOLDERS AND ALL BENEFICIAL HOLDERS OF REVANCE THERAPEUTICS, INC. (“REVANCE” OR THE “COMPANY”) COMMON STOCK WHO HELD SUCH STOCK AS...
Monteverde & Associates PC and Kahn Swick & Foti, LLC Announce Proposed Class Action Settlement on Behalf of Holders of Revance Therapeutics, Inc. Common Stock
